Se connecter Inscription gratuite

Novabay Pharmaceuticals Inc Ret. sur les actifs

Quel est le Ret. sur les actifs de Novabay Pharmaceuticals Inc?

Le Ret. sur les actifs de Novabay Pharmaceuticals Inc est -136.86%

Quelle est la définition de Ret. sur les actifs?



Le rendement des actifs indique dans quelle mesure les actifs d'une entreprise génèrent des revenus. Il est calculé en divisant le résultat net par l'actif total moyen.

The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.

Ret. sur les actifs des entreprises dans Health Care secteur sur NYSEMKT par rapport à Novabay Pharmaceuticals Inc

Que fait Novabay Pharmaceuticals Inc?

novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across

Entreprises avec ret. sur les actifs similaire à Novabay Pharmaceuticals Inc